These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1198070)

  • 1. A solid-phase radioimmunoassay for C1q-binding immune complexes. I. Delta IgG as indicator molecule.
    Svehag SE
    Scand J Immunol; 1975; 4(7):687-97. PubMed ID: 1198070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of IgG aggregates or immune complexes using solid-phase C1q and protein A-rich Staphylococcus aureus as an indicator system.
    Farrell C; Sogaard H; Svehag SE
    Scand J Immunol; 1975; 4(7):673-80. PubMed ID: 1198069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid-phase Clq-binding fluorescence immunoassay for detection of circulating immune complexes.
    Collins MM; Casavant CH; Stites DP
    J Clin Microbiol; 1982 Mar; 15(3):456-64. PubMed ID: 6804486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of C1q-binding immune complexes by affinity chromatography and desorption with a diaminoalkyl compound.
    Svehag SE; Burger D
    Acta Pathol Microbiol Scand C; 1976 Feb; 84(1):45-52. PubMed ID: 773099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus.
    Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
    Clin Exp Immunol; 1987 Jul; 69(1):98-106. PubMed ID: 3498589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
    Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
    J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1q solid-phase radioimmunoassay: binding properties of solid-phase C1q and evidence that C1q-binding IgG complexes in systemic lupus erythematosus are not bound to endogenous C1q.
    Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
    J Immunol Methods; 1984 Oct; 73(1):67-74. PubMed ID: 6436382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of the fluid phase C1q binding assay. The effect of endogenous C1q on the precipitation and detection of an immune complex model.
    Jacobs RJ; Mocharla R
    J Immunol Methods; 1988 May; 109(2):265-75. PubMed ID: 3258897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
    Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
    Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey for circulating immune complexes in patients with acute myocardial infarction. Use of a C1q-binding assay with soluble protein A as indicator.
    Farrell C; Bloth B; Nielsen H; Daugharty H; Lundman T; Svehag SE
    Scand J Immunol; 1977; 6(12):1233-40. PubMed ID: 605362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IgG detected in the C1q solid-phase immune-complex assay is not always of immune-complex nature.
    Hack CE; Belmer AJ
    Clin Immunol Immunopathol; 1986 Jan; 38(1):120-8. PubMed ID: 3484437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective binding of heat- and antigen-aggregated IgG to Blue-Sepharose. Radioimmunoassay of circulating immune complexes.
    Dobre MA; Moţa G
    J Immunol Methods; 1983 Dec; 65(1-2):207-15. PubMed ID: 6655240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between clinical disease, circulating antibodies and C1q-binding immune complexes in human onchocerciasis.
    Sisley BM; Mackenzie CD; Steward MW; Williams JF; O'Day J; Luty AJ; Braga M; el Sheikh H
    Parasite Immunol; 1987 Jul; 9(4):447-63. PubMed ID: 3498141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both IgG- and C1q-receptors play a role in the enhanced binding of IgG complexes to human mesangial cells.
    van den Dobbelsteen ME; van der Woude FJ; Schroeijers WE; Klar-Mohamad N; van Es LA; Daha MR
    J Am Soc Nephrol; 1996 Apr; 7(4):573-81. PubMed ID: 8724891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
    J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q.
    Hay FC; Nineham LJ; Roitt IM
    Clin Exp Immunol; 1976 Jun; 24(3):396-400. PubMed ID: 939046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of immune complexes by competitive inhibition of binding of Clq to insoluble IgG aggregates.
    Fletcher DS; Lin TY
    J Immunol Methods; 1977; 15(1):39-45. PubMed ID: 845441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
    Nydegger UE; Lambert PH; Gerber H; Miescher PA
    J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.